Kevin Hern shares opinions on Trump’s achievements and Democrats’ strategies

Kevin Hern shares opinions on Trump’s achievements and Democrats’ strategies
Rep. Kevin Hern, U.S. Representative for Oklahoma's 1st District — Twitter Website
0Comments

Congressman Kevin Hern, representing Oklahoma’s 1st district since 2018, has been active on social media with a series of tweets expressing his political views and activities. Hern, who replaced Jim Bridenstine in Congress, has a background in education from Arkansas Tech University and the University of Arkansas, Little Rock.

On January 31, 2025, Congressman Hern announced his appearance on Newsmax with a tweet stating: “Joining @NEWSMAX live — tune in!”.

Later that day, Hern shared his thoughts on the political strategies of Democrats regarding former President Trump. He tweeted: “Democrats want to fight Trump in Congress, in the courts, and even in the streets, according to the leader of the Democrat Party, @RepJeffries. President Trump has done more in 11 days than Joe Biden did in four years.”

On February 1, 2025, Congressman Hern expressed support for actions taken by the Trump-Vance Administration with another tweet: “Another great move from the Trump-Vance Administration!”



Related

Sara Brenner, Principal Deputy Commissioner at FDA

43 companies in cities within Tulsa County received 43 inspections in 2025

There were 43 companies in cities associated with Tulsa County that received 43 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Sean R. Keveney J.D., Chief Counsel of FDA

Cities located in Osage County saw FDA inspections of 39 companies in 2025

There were 39 companies in cities associated with Osage County that received 39 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Jim Traficant, Chief of Staff of FDA

Wagoner County cities: 39 companies received FDA inspections in 2025

There were 39 companies in cities associated with Wagoner County that received 39 FDA inspections in 2025, according to the U.S. Food and Drug Administration.